1Reader, College of Nursing, Christian Medical College, Vellore, India
2Professor, College of Nursing, Christian Medical College, Vellore, India
*Corresponding Author: Mrs. Angelin Esther, Reader, College Of Nursing, Christian Medical College, Vellore, India, Email: esthu80@gmail.com
Online published on 6 January, 2018.
AntiPhosphoLipid Antibody Syndrome (APLAS/APS) is an auto immune disorder that manifests clinically as or recurrent venous arterial thrombosis and/or fetal loss. Almost all auto immune diseases appear without warning or apparent cause. Diagnosing APLA Syndrome is complex and requires extensive laboratory tests. The hallmark result from laboratory tests that defines APLAS is the presence of AntiPhosphoLipid Antibodies (APLA) or abnormalities in phospholipid-dependent tests of coagulation. Once the disease is diagnosed, adequate therapy and meticulous nursing care is vital to prevent the recurrence of the symptoms.
AntiPhosphoLipid Antibody Syndrome (APLAS/APS), autoimmune, phospholipids, AntiPhosphoLipid Antibodies (APLA), Thrombosis, SLE